Objective: To perform a systematic review and meta-analysis to estimate the effect of endometriosis on preterm birth (PB) risk. Methods: Searches were conducted in PubMed-MEDLINE, Embase, Scopus, Web of Science, Cochrane Library, Google Scholar, and SciELO for studies published in all languages from inception through April 2017. We included cohort studies evaluating pregnant women with and without endometriosis and conception either by spontaneous conception (SC) or with assisted reproductive technology (ART). Primary outcome was PB (<37 weeks), and secondary outcomes were intrauterine growth restriction (IUGR), low birthweight, small for gestational age (SGA), and birthweight. Pooled odds ratios (ORs) and its 95% confidence interval (CI) were calculated as effects, and random-effects models were used for meta-analyses. Risk of bias was assessed with the Newcastle-Ottawa Scale, and heterogeneity of effects among studies was described with the I 2 statistic. Results: We identified 9 cohort studies including a total of 1 496 715 pregnancies (13 798 with endometriosis diagnosis). In women with endometriosis, the PB risk was significantly increased in both SC (OR: 1.59; 95% CI: 1.32-1.90) and ART (OR: 1.43; 95% CI: 1.14-1.79). The SGA risk was increased in women with endometriosis (OR: 1.16; 95% CI: 1.05-1.28), while the IUGR and low birthweight risks and birthweight were not affected by endometriosis. Conclusion: Endometriosis is associated with increased PB risk in both SC and women who obtained pregnancy using ART. Prospective studies evaluating relevant outcomes are needed to confirm these results.
Introduction
Endometriosis is a mysterious disease that affects 10% to 15% of women during reproductive years and has been associated with genetic, angiogenic, inflammatory, immune, and uterine disorders. [1] [2] [3] [4] The main symptoms are chronic pelvic pain and infertility. Some large-scale studies showed a prevalence of endometriosis in 25% to 40% of infertile women, 5, 6 as well as low basal ovarian reserve, low fertility rate, and embryo cleavage. 7 In addition, the pro-inflammatory and angiogenic factors in the ectopic endometrium may contribute to abnormal placentation 2, 8 and to develop major obstetrical complications including activation of the mechanisms involved in preterm birth (PB) 1, 2, 9 ; newborns of these women need more frequent neonatal intensive care unit admissions. 10 However, other studies reported that complications of endometriosis are rare and have no major negative effect on pregnancy outcomes. 11 Many women with endometriosis should have undergone artificial reproductive technology (ART) to get pregnant. 12 Procedures used in ART may have a crucial role in maternal and fetal complications in comparison with spontaneous conception (SC). 13 All ART methods have increased risk of obstetric and perinatal complications, suggesting that infertility-related maternal factors contribute to the adverse outcomes rather than ART.
14 A systematic review and metaanalysis reported that women with endometriosis who had in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) have similar live birth rate/woman, lower clinical pregnancy rate/woman, and similar miscarriage rate/ woman. 15 Another meta-analysis reported that pregnancies after ART have increased risk of complications and adverse pregnancy outcomes when compared to naturally conceived gestations. 16 The objective of this systematic review and meta-analysis was to evaluate the association of endometriosis and PB in women who had SC or used ART to treat infertility. Secondary outcomes were also studied, including intrauterine growth restriction (IUGR), small for gestational age (SGA), low birthweight risks, and birthweight.
Sources, Study Selection, and Methods
This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 17 Formal institutional review board approval was not required because this analysis consisted of pooling published studies.
Literature Search
We searched all published and unpublished observational studies from inception to April 15, 2017, on "Endometriosis" or "Endometrioma" and "Preterm birth" or "Preterm delivery" or "Premature birth" outcomes. The following electronic databases were searched: PubMed-Medline, Embase, Scopus, Web of Science, Cochrane Library, Google Scholar, and SciELO. The search strategy was initially developed for use in PubMedMedline and was then adapted for searching the other databases. In addition, references from selected articles were hand searched and revised for inclusion.
Eligibility Criteria and Study Selection
The exposed group consisted of pregnant women with endometriosis who conceived after SC or with ART. The unexposed group included pregnant women without a history of endometriosis. Inclusion criteria were as follows: (1) cohort or casecontrol studies comparing the incidence of PB between pregnant women with endometriosis and pregnant women without endometriosis; (2) study in any language; and (3) studies reporting estimates of odds ratio (OR) for categorical variables and mean differences and standard deviation for continuous variables with a measure of variability such as the 95% confidence interval (CI) or sufficient data to be calculated. Additionally, studies were excluded if (1) the paper was a review or a conference abstract, (2) the study had no control group, (3) the study involved women with illnesses other than endometriosis, (4) there was no information on PB, (5) the study combined SC and using ART results, or (6) the studies were conducted in animals.
After an independent screening of retrieved titles and abstracts by 2 investigators (M.M-O. and P.V-B.), the full texts of all potentially eligible studies were retrieved. Four review authors (A.M-G., M.M-O., P.C-A., and P.V-B.) independently examined these articles for compliance with the inclusion criteria and selected the studies that were eligible for inclusion in the review. Disagreements about study eligibility were resolved after discussion with a fifth author (F.R.P-L.). Study investigators were contacted if clarification was needed for study eligibility.
Data Extraction and Risk of Bias Assessment
Two pairs of authors (first pair: M.M-O. and P.V-B.; second pair: A.M-G. and P.C-A.) independently extracted the data using a data extraction form designed and pilot tested by the authors on 2 independent occasions. Any disagreements were resolved by discussion between both peers and a fifth author (F.R.P-L.). Data retrieved included study characteristics, patient characteristics, and outcomes. Both pairs double checked these extracted data. Where studies had multiple publications or were using the same database, the latest and main study report was used as the reference and additional details were scanned from the secondary or earlier papers.
The ascertainment of having a diagnosis of endometriosis was achieved by different conventional procedures including clinical diagnosis, image diagnosis (pelvic ultrasound, magnetic resonance image), laparoscopy or laparotomy, and/or biopsy.
The risk of bias of individual studies was assessed in accordance with the Newcastle-Ottawa Scale (NOS). 18 The NOS was used independently by the same pairs of authors. Any disagreements were resolved by discussion between both sides and a fifth author (F.R.P-L.). The NOS evaluates 8 items of selection of exposure and nonexposure groups and comparability of exposure and nonexposure groups, and an additional star can be assigned for comparability on the basis of the design or analysis. Therefore, the outcome evaluation may reach a maximum number of 9 stars. A total of 7 or more stars implies that the study has a low risk of bias.
Outcomes
Primary outcome was PB (<37 weeks), and secondary outcomes were IUGR (as defined by the authors), SGA (10th percentile for the gestational age), low birthweight (<2500 g), and birthweight difference.
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Statistical Analyses
We planned to use the Mantel-Haenszel fixed-effects model for meta-analyses as we expected scarce outcomes; however, as several population-based studies with large sample size were included and high heterogeneity observed, finally randomeffects models were used for meta-analyses. 19 Odds ratio and its 95% CI was the metric used to describe the association between endometriosis and outcomes. We evaluated whether the clinical characteristics of the included studies (such as population-based or clinical-based sample, endometriosis ascertainment, outcomes ascertainment and adjustments, mode of conception, parity, and geographical region of the studied sample) were sufficiently similar for meta-analysis to provide a clinically meaningful summary.
Statistical heterogeneity was evaluated by the measure of the I 2 as recommended by the Cochrane handbook. 20 We considered an I 2 value of 0% to 30% to represent low heterogeneity, 30% to 60% moderate heterogeneity, and >60% substantial heterogeneity. A P value <.1 for the w 2 test indicated presence of heterogeneity; a t 2 > 1 suggests the presence of substantial statistical heterogeneity. Potential publication bias was estimated by Begg funnel plot and Egger linear regression test. 21 We predefined the evaluation of subgroups by type of diagnosis (histological diagnosis vs other procedures), type of sample (clinically based sample vs population-based sample), and world region (F.R.P-L. and A.V-H.). Statistical analyses were conducted using Review Manager (RevMan 5.2; Cochrane Collaboration, Oxford, United Kingdom) and Comprehensive Meta-Analysis (version 2; Biostat, Englewood, New Jersey). 22 
Results

Eligible Studies
We found 1126 abstracts. After removing duplicates, 860 abstracts were evaluated. Of these, 150 fulfilled our inclusion criteria, and 67 abstracts remained for full-text assessment. This process ended up in 27 full papers for evaluation; in addition, 4 papers were manually identified. Twenty-two papers were excluded for different reasons, including the lack of report for individualized/separated data for SC and for pregnancies obtained with ART ( Figure 1) . Therefore, 9 articles were qualitative and quantitatively assessed in the current systematic review and meta-analysis. Table 1 summarizes the main characteristics of the studies included in the systematic review. [23] [24] [25] [26] [27] [28] [29] [30] [31] Women who had any illnesses that may affect the pregnancy course were not included in the review. There was a total of 9 cohort studies (n ¼ 1 496 715): 4 were clinical cohort studies 23, 25, 28, 29 and 5 population-based studies were linked to large national or This study included women diagnosed both before and after pregnancy, under the hypothesis that women who were not diagnosed until after pregnancy were also affected by endometriosis during pregnancy.
Study Characteristics
regional health registries. 24, 26, 27, 30, 31 Studies were 5 from Europe, 2 from Japan, 1 from the United States, and 1 from Australia. All papers were in English, except for 1 study in French. 23 Sample sizes ranged from 40 to 13 090 women with endometriosis (Table 1) . 29, 30 Endometriosis diagnosis was reported by histopathological analysis in 4 studies, whereas in the remaining studies, diagnoses were done by clinical approaches including other procedures (ultrasound, magnetic resonance, or data health register; Figure 2 ). Endometriosis was diagnosed before pregnancy except in 1 article, 26 in which the diagnosis was established under the hypothesis that women who were not diagnosed until after pregnancy were also affected by endometriosis during pregnancy. Five studies reported data of spontaneous pregnancies, 26, [28] [29] [30] [31] and 7 studies reported data of pregnancies achieved by ART (Table 1) .
23-27,29,31
Risk of Bias Assessment
All observational studies had low risk of bias according to the NOS (Supplementary Table 1 ). The reported information about endometriosis was according to the International Classification of Diseases diagnosis, conventional clinical diagnosis and complementary examinations, and/or Health and Diseases Regional or National Registries. Effects were adjusted, stratified, or matched for different factors (age, parity, infertility and use of ARTs, smoking, body mass index) in a large number of cohort studies (Table 1) .
Meta-Analyses
Primary and secondary outcomes. Preterm birth risk was significantly higher in women with endometriosis compared to women without endometriosis in both SC (OR: 1.59, 95% CI: 1.32-1.90, I
2 ¼ 52%) and pregnancies obtained using ART (OR: 1.43, 95% CI: 1.14-1.79, I
2 ¼ 54; Figure 2 ). There was no evidence of asymmetry of the funnel plot ( Supplementary Figure 1) with the Egger test (P ¼ .22) or interdependence of variance and effect size with the BeggMazumdar test (P ¼ .34); therefore, there is no suggestion of publication bias.
The SGA risk was higher in women with endometriosis (OR: 1.16, 95% CI: 1.05-1.28, I
2 ¼ 0%), while there were no significant differences in the low birthweight and IUGR risks (Figure 3 ). Mean newborn birthweight in pregnant women with and without endometriosis did not show significant difference (Figure 4) . Subgroup analyses. The PB risk in women whose endometriosis was diagnosed by biopsy and histological assessment was similar to women with other forms of the disease diagnosis (Supplementary Figure 2) . A second subanalysis showed that the PB risk in women from clinically based studies versus women from population-based studies had similar risk of PB (Supplementary Figure 3) . A third subgroup analysis showed that the PB risk was similar in European and Japanese studies, while there was only 1 study from the United States and 1 from Australia (Supplementary Figure 4) . In addition, there was not enough information to assess the PB risk by endometriosis types (ie, peritoneal, ovarian, or deep endometriosis). Heterogeneity of studies in subgroup analyses was moderate to high (Supplementary Figures 2-4) .
Discussion
To the best of our knowledge, this is the first systematic review and meta-analysis that evaluated the association of endometriosis and PB risk in pregnancies obtained either by SC or after application of ART. It seems that the increased risk of PB was similar in both circumstances. At the same time, there is an increase in SGA risk in women with endometriosis in comparison with women without the disease, for both reproductive manners, while there were no significant differences for the low birthweight and the IUGR risks. In addition, newborns Reproductive Sciences 25 (3) from mothers with endometriosis had no differences in birthweight with respect to those without endometriosis. Subgroup analyses did not show any influence on the PB risk when considering endometriosis diagnosis procedures, clinically based versus population-based studies, or geographic regions. Our comprehensive search strategy included all languages without restriction in 7 databases. We did not restrict for specific endometriosis diagnostic methods; we also included studies with small samples along with big sample studies for meaningful evaluation of eventual publication bias. All endometriosis forms were included since they have similar performance on ART. 32 Another strength of the review was that reported obstetric and neonatal outcomes had standard definitions according to international recommendations. In addition, a larger number of studies allowed for subgroup analyses to assess eventual sources of heterogeneity by study characteristics. Therefore, the studied sample is representative of the current clinical management of endometriosis in different setups and different world regions, including both SC and a large number of patients treated with ART. However, it is interesting that low PB rate in both study and control groups, even in population-based studies, may be related to confounding factors and deserve future specific studies.
Women with endometriosis or endometriomas sent to ART seem to have similar reproductive results in terms of clinical pregnancy and live births than women without endometriosis.
11
A systematic review without meta-analysis concluded that endometriosis did not have a major negative impact on pregnancy outcomes during the second half of pregnancy. 13 Our systematic review and meta-analysis found a significant association of endometriosis and PB risk. This syndrome may be due to multiple causes, and the final path will be associated with inflammatory changes and uterine changes, including contractions and fetal delivery. 33, 34 Endometriosis may promote local and systemic inflammatory response which may induce alterations in inflammatory mediators [35] [36] [37] that may contribute to the labor initiation and PB. 1 The proinflammatory status may be associated with vascular abnormalities and decidual senescence that may interfere with pregnancy success, including PB, fetal growth restriction, and placental alterations. 38, 39 On the other hand, uterine junctional zone alterations have also been reported in women with early endometriosis. 40 These lesions are similar to those found in adenomyosis, although less severe. 41 One or several of these endometriosis-associated alterations may contribute to the increased PB risk.
Our study found a significant increase in the SGA risk in women with endometriosis and did not detect IUGR and low birthweight risks or differences in mean birthweights between newborns from mothers with and without endometriosis. In women with endometriosis, IUGR and the SGA risks have been related to the most severe forms of the disease. 10 In our meta-analysis, the rate of SGA was higher in women with endometriosis, and interestingly, the birth weight in those patients was higher (although not significant) than in the nonendometriosis group. Better, larger studies are needed to confirm whether that trend reached significance or is it related to confounding factors.
Women with advanced stages of endometriosis treated with IVF and ICSI have a negative impact on the risk of live birth. 42 The inflammatory environment, vascular abnormalities, and defective placentation may contribute to reduce fetal growth and the increased risk of SGA reported here. These alterations may reduce nutrition and oxygenation in the fetal compartment. Further studies are needed to determine the biochemical links between endometriosis and PB and to design preventive strategies for preterm deliveries, SGA, and stillbirths.
Our study had some limitations related to available publications. First, observational studies have several biases that may have not been completely taken care of in studies, and associations are prone to remaining bias. Second, we also identified heterogeneous clinical definitions of endometriosis. However, all endometriosis diagnoses that we used were previously accepted by the scientific community in the context of primary reports. Third, the endometriosis extension was heterogeneously reported by clinical severity or disease stages, which did not allow to make comparisons and subgroup analyses. However, the most used American Society of Reproductive Medicine classification 43 is based on visual pelvis appearance during laparoscopy or laparotomy, which is neither always feasible nor needed. In addition, correlations between symptom severity and stages are very weak. 44 On the other hand, available primary evidence did not report separated information by types of endometriosis (eg, peritoneal, ovarian, and deep endometriosis) or obstetric outcomes. Fourth, the lower rate of PB in both women with and without endometriosis may be related to confounding factors. Finally, we could not evaluate information about ART procedures (such as medications, culture media composition, length of culture, the freezing of embryos, the risk of altered of hormone environment at the implantation, or several of these factors) that might contribute to adverse obstetric outcomes, 13, 45 as it was lacking in the reports of selected studies.
Our study suggested that the PB risk seems to be similarly increased in SCs and in those who obtained pregnancy with ART. Some studies suggested that singleton conception after ART had increased maternal and neonatal outcome risks. 46 In addition, perinatal adverse outcomes are more frequent in the same mothers with ART singleton than in SC sibling, suggesting epigenetic modifications in human gametes and/or embryos due to hormone treatments and/or laboratory manipulations. 47 
Conclusion
This systematic review and meta-analysis demonstrated that endometriosis increases the risk of PB. This association was irrespective of the type of reproduction: SCs or using ART. In addition, women with endometriosis had increased risks of SGA. There were no significant differences in IUGR, low birthweight, and birthweight. Our findings suggested that women with endometriosis should be included among those who may need special care during pregnancy to prevent obstetric and neonatal complications. Finally, future better designed research with common standardized end points on women with endometriosis is needed to confirm the findings of our study.
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